3-Formylbenzoic acid
3-Formylbenzoic acid structure
|
Common Name | 3-Formylbenzoic acid | ||
|---|---|---|---|---|
| CAS Number | 619-21-6 | Molecular Weight | 150.131 | |
| Density | 1.3±0.1 g/cm3 | Boiling Point | 331.7±25.0 °C at 760 mmHg | |
| Molecular Formula | C8H6O3 | Melting Point | 173-175 °C(lit.) | |
| MSDS | USA | Flash Point | 168.6±19.7 °C | |
| Symbol |
GHS07 |
Signal Word | Warning | |
|
Novel styrylbenzene derivatives for detecting amyloid deposits.
Clin. Chim. Acta 436 , 27-34, (2014) Various styrylbenzene compounds were synthesized and evaluated as mainly Aβ amyloid sensors. These compounds, however, cannot be used for detecting amyloid deposition in peripheral nerves because of the inherent sensitivity of the compounds. These compounds o... |
|
|
Synthesis and evaluation of 3-(dihydroxyboryl)benzoic acids as D,D-carboxypeptidase R39 inhibitors.
J. Med. Chem. 52 , 6097-106, (2009) Penicillin binding proteins (PBPs) catalyze steps in the biosynthesis of bacterial cell walls and are the targets for the beta-lactam antibiotics. Non-beta-lactam based antibiotics that target PBPs are of interest because bacteria have evolved resistance to t... |
|
|
Synthesis of Alicyclic-lactams via the Ugi Reaction on a Solid Support. Gedey S, et al.
Lett. Org. Chem. 1(3) , 215-20, (2004)
|
|
|
Synthesis, binding properties and self-functionalization of a steroid-capped porphyrin. Richard P and Jeremy KM.
J. Chem. Soc. Chem. Commun. 8 , 574-77, (1991)
|
|
|
Synthesis of 4-amino-6-(hetero)arylalkylamino-1,2,4-triazolo[4,3-a]quinoxalin-1-one derivatives as potent A(2A) adenosine receptor antagonists.
Bioorg. Med. Chem. 11(24) , 5509-18, (2003) In previous papers (Colotta, V. et al. Arch. Pharm. Pharm. Med. Chem. 1999, 332, 39. Colotta, V. et al. J. Med. Chem. 2000, 43, 1158) we reported the synthesis and binding affinity at bovine (b) A(1) and A(2A) and human (h) A(3) adenosine receptors (ARs) of t... |
|
|
Impact of linker strain and flexibility in the design of a fragment-based inhibitor.
Nat. Chem. Biol. 5 , 407-13, (2009) The linking together of molecular fragments that bind to adjacent sites on an enzyme can lead to high-affinity inhibitors. Ideally, this strategy would use linkers that do not perturb the optimal binding geometries of the fragments and do not have excessive c... |